Nutrien Reports Strong Q1 2026 Results, Reaffirms Guidance, and Continues Share Buybacks

summarizeSummary

Nutrien reported strong first-quarter 2026 results with a 30% increase in adjusted EBITDA, reaffirmed its full-year guidance, and returned $409 million to shareholders through dividends and share repurchases.

check_boxKey Events

• Strong Q1 2026 Financial Performance

  Adjusted EBITDA increased 30% to $1.11 billion in Q1 2026 from $852 million in Q1 2025. Net earnings rose significantly to $139 million ($0.27 diluted EPS) from $19 million ($0.02 diluted EPS) in the prior year period.

• Full-Year Guidance Reaffirmed

  The company maintained all 2026 full-year financial and operational guidance ranges, including Retail adjusted EBITDA of $1.75 to $1.95 billion and Potash sales volumes of 14.1 to 14.8 million tonnes.

• Significant Capital Returns to Shareholders

  Nutrien returned $409 million to shareholders in the first quarter of 2026 through dividends and share repurchases. This included $147 million in share repurchases during Q1 2026, with an additional $66 million repurchased subsequent to quarter-end as of May 5, 2026.

• Operational Highlights and Strategic Progress

  The company achieved record potash sales volumes and stronger performance in its Nitrogen and Retail segments. It also completed a tuck-in acquisition of a high-quality retail business in the US corn belt and is progressing with the review of strategic alternatives for its Phosphate business, Trinidad Nitrogen facility, and Brazilian Retail business.

auto_awesomeAnalysis

Nutrien Ltd. delivered a robust first quarter, significantly increasing adjusted EBITDA and net earnings, driven by strong customer demand, record potash sales, and improved performance in its Nitrogen and Retail segments. The reaffirmation of full-year guidance signals management's confidence in sustained operational strength and market conditions, despite ongoing geopolitical uncertainties impacting global fertilizer markets. The continued return of substantial capital to shareholders through dividends and share repurchases further reinforces a disciplined capital allocation strategy. Investors should interpret these results as a strong positive signal for the company's financial health and operational execution.